Transplantation, AutologousHematopoietic Stem Cell TransplantationTransplantation, HomologousTransplantation ConditioningLiver TransplantationGraft vs Host DiseaseBone Marrow TransplantationStem Cell TransplantationHematologic NeoplasmsKidney TransplantationMyeloablative AgonistsPeripheral Blood Stem Cell TransplantationGraft SurvivalWhole-Body IrradiationTissue DonorsTreatment OutcomeTransplantation ChimeraHeart TransplantationUnrelated DonorsCell TransplantationHistocompatibility TestingLung TransplantationMultiple MyelomaHematopoietic Stem Cell MobilizationHematopoietic Stem CellsCord Blood Stem Cell TransplantationRecurrenceRetrospective StudiesGraft RejectionHistocompatibilityImmunosuppressive AgentsBusulfanGraft vs Tumor EffectSurvival AnalysisTransplantation ImmunologyTransplantationRemission InductionCombined Modality TherapyOrgan TransplantationSurvival RateDisease-Free SurvivalLeukemiaTime FactorsMelphalanLymphoma, Non-HodgkinVidarabineLeukemia, Myeloid, AcuteIslets of Langerhans TransplantationPancreas TransplantationAntigens, CD34CyclophosphamideHLA AntigensSalvage TherapyFollow-Up StudiesLiving DonorsSiblingsDonor SelectionChimerismMyelodysplastic SyndromesGraft vs Leukemia EffectAntineoplastic Combined Chemotherapy ProtocolsImmunosuppressionHematopoiesisGranulocyte Colony-Stimulating FactorTransplantation, IsogeneicCyclosporineHodgkin DiseaseBone Marrow CellsCarmustineHematologic DiseasesBone Marrow PurgingLeukapheresisMycophenolic AcidTransplantation, HeterotopicAcute DiseaseMesenchymal Stem Cell TransplantationPrognosisPrecursor Cell Lymphoblastic Leukemia-LymphomaHeart-Lung TransplantationAntilymphocyte SerumDirected Tissue DonationTransplantation ToleranceT-LymphocytesTacrolimusRisk FactorsPostoperative ComplicationsAnemia, AplasticBone MarrowLymphocyte TransfusionTissue and Organ ProcurementEtoposideLeukemia, Myelogenous, Chronic, BCR-ABL PositiveSurvivorsLymphomaCytomegalovirus InfectionsFetal Tissue TransplantationCytarabineHepatic Veno-Occlusive DiseaseAllograftsNeoplasm, Residual